Spyre Therapeutics, Inc. (SYRE) – What Are Analysts Saying About This Stock?
Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating […]
4 Nov 04:29 · The Cerbat Gem